Sudeep Pharma Limited IPO Details
MAINBOARD
Sudeep Pharma IPO DRHP (Draft Red Herring Prospectus) has been Filed With SEBI.
Offer for Sale consists of 1,00,76,492 shares .
The Lead Managers for Sudeep Pharma IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is ICICI Securities Limited, IIFL Capital Services Limited. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For detailed information, Refer to the Sudeep Pharma Limited DRHP.
Sudeep Pharma IPO Details
Sudeep Pharma IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
To be announced | |||
Sudeep Pharma IPO Reservation
Promoter Holding
Documents
Sudeep Pharma IPO Valuations
Sudeep Pharma Financial Information
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 656.92 | 513.87 | 420.11 | 345.00 |
| Revenue | 350.02 | 465.38 | 438.26 | 351.00 |
| Profit After Tax | 94.54 | 133.15 | 62.32 | 49.80 |
| EBITDA | 136.74 | 187.76 | 98.64 | 75.15 |
| Net Worth | 453.36 | 359.07 | 226.29 | 163.92 |
| Reserves and Surplus | 437.75 | 354.59 | 221.88 | 161.40 |
| Total Borrowing | 117.20 | 75.03 | 82.26 | 83.71 |
| Amount in ₹ Crore | ||||
About Sudeep Pharma IPO
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.
The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium
The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors
The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients.
Product Portfolio:
- Pharmaceutical, Food and Nutrition Business
- Specialty Ingredients Business
- Triturates
As of December 31, 2024, the company had 704 permanent employees.
Strength Of Sudeep Pharma IPO
Risk Of Sudeep Pharma IPO
Objectives Sudeep Pharma IPO
1. Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I
2. General corporate purposes
Company Contact Details
Sudeep Pharma Limited
129/1/A,
GIDC Estate,
Nandesari,
Vadodara, Gujarat, 391340
Phone: +91 265 284 0656
Email: cs.sudeep@sudeepgroup.com
Website: https://www.sudeeppharma.com/